976P HM97662, a novel EZH1/2 dual inhibitor, in patients with advanced or metastatic solid tumors: Initial results from a first-in-human phase I study

作者：B. Keam, Kitae Kim, Vinod Ganju, Lisi Elizabeth Lim, V. Kwatra, Amy Body, P.D. Rhee, William Lee, Hoon Jang, Young Su Noh, J-H. Ahn · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.08.1545 · 被引用次数：1 · 研究领域：Epigenetics and DNA Methylation、Histone Deacetylase Inhibitors Research、Cancer, Hypoxia, and Metabolism